Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.045 USD | -3.08% | -5.76% | -38.59% |
05-13 | Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating | MT |
05-09 | Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.59% | 242M | |
+10.86% | 115B | |
+12.33% | 106B | |
-4.34% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-12.85% | 17.56B | |
-40.50% | 17.32B | |
+6.41% | 14.03B | |
+31.30% | 12.13B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Transcript : Coherus BioSciences, Inc., Q1 2024 Earnings Call, May 09, 2024